GLIS3 and neoplasm: Table 1 lists the detailed clinical features. Among 375 subjects, 188 demonstrated high GLIS3 expression, and 187 demonstrated low expression. There were 134 men and 241 women present. The average age of the participants was 65. The mean age of all participants was 65 years. Stage STAD: 53 patients in stage I, 111 in stage II, 150 in stage III, and 38 in stage IV. GLIS3 expression was connected with regional lymph node condition, PFI event, DSS event, and Anatomic neoplasm subdivision (Table 1)